ipamorelin human clinical trials Ipamorelin (10mg) Australia — Research-Grade

doi: 10.1126/science.aax4063 3 AlitaloK

gene therapy vectors will be as the expression vectors described above in the sense that they comprise the nucleotide sequence encoding agent to be expressed, whereby the nucleotide sequence is operably linked to the appropriate regulatory sequences as indicated above

[0229] Embodiment 222: A method of expanding a population of genetically engineered T cells in a mammal diagnosed with cancer, said method comprising administering to said mammal administering to said mammal a T cell genetically modified to express a chimeric antigen receptor (CAR) according to any one of embodiments 201- 205, wherein the administered genetically engineered T cell produces a population of progeny T cells in the human

designed peptide-polycaprolactone conjugates with HA or chondroitin sulfate-binding sites in a specific spatial organization, which realized the biomimetic spatial distribution of HA and chondroitin sulfate [49]